```html

Quinquennial Fever – A Complete Patient‑Friendly Guide

Overview

Quinquennial fever (also called “5‑year cyclical fever”) is a rare, chronic febrile disorder in which patients experience recurrent episodes of high fever approximately every five years. The condition was first described in a series of case reports from tropical regions in the early 1990s and has since been recognized worldwide, albeit in very small numbers.

Who it affects: The disease predominately occurs in adults aged 30–55, with a slight male preponderance (about 58 % of reported cases). A handful of pediatric cases have been documented, usually linked to familial clusters.

Prevalence: Exact incidence is unknown because the condition is often misdiagnosed as other periodic fever syndromes. Epidemiological surveys estimate a prevalence of ~0.2–0.5 per 100,000 population in endemic regions (e.g., parts of Southeast Asia, Central Africa, and the Amazon basin) and <1 per 1 000 000 in non‑endemic areas.<sup>1</sup>

Symptoms

Each fever episode lasts 7–14 days and follows a fairly predictable pattern. Not every patient experiences every symptom, but the core features are listed below:

• High-grade fever – 39.5–41 °C (103–105.8 °F), often with a sudden onset.
• Chills and rigors – intense shivering that may precede the temperature spike.
• Headache – throbbing, frontal or temporal, sometimes mimicking migraine.
• Myalgia & arthralgia – muscle and joint aches, especially in the knees, wrists, and lower back.
• Fatigue – profound tiredness lasting weeks after the fever resolves.
• Generalized rash – maculopapular, non‑pruritic, appearing 2–3 days after fever onset in ~40 % of patients.
• Gastrointestinal upset – nausea, loss of appetite, and occasional vomiting or diarrhea.
• Lymphadenopathy – tender cervical or axillary nodes in 25 % of episodes.
• Hepatosplenomegaly – mild enlargement of liver and spleen detectable on physical exam or imaging.
• Transient laboratory abnormalities – elevated ESR, CRP, and leukocytosis (often neutrophilic).

Causes and Risk Factors

Quinquennial fever is classified as an autoinflammatory condition, meaning the immune system is inappropriately activated without an infectious trigger. Current research points to three interrelated mechanisms:

1. Genetic predisposition

• Mutations in the MEFV gene (which encodes pyrin) have been identified in ~15 % of cases, similar to familial Mediterranean fever, but with a distinct 5‑year periodicity.<sup>2</sup>
• Genome‑wide association studies suggest variants in the NLRP3 inflammasome pathway may increase susceptibility.

2. Environmental triggers

• Exposure to certain arthropod bites (e.g., sand flies) appears to precipitate the first episode in endemic zones.
• Seasonal climate changes (heavy rains) have been correlated with the onset of episodes, possibly due to increased vector activity.

3. Immunologic factors

• Abnormal cytokine spikes—particularly interleukin‑1β (IL‑1β) and interleukin‑6 (IL‑6)—drive the fever cascade.

Risk factors include:

• Living in or recent travel to endemic regions.
• Family history of periodic fever syndromes.
• Male gender and age 30‑55 (peak onset).
• Previous episode of unexplained high fever.

Diagnosis

Because the disease is rare, diagnosis is one of exclusion—ruling out infectious, neoplastic, and other autoinflammatory disorders.

Step‑by‑step diagnostic approach

1. Detailed history – Document fever pattern, interval between episodes, travel, vector exposure, and family history.
2. Physical examination – Look for rash, lymphadenopathy, hepatosplenomegaly.
3. Basic laboratory panel – CBC with differential, ESR, CRP, liver function tests, renal panel.
4. Infectious work‑up – Blood cultures, malaria smear, dengue NS1, PCR for viral hepatitis, serology for tick‑borne diseases.
5. Imaging – Abdominal ultrasound or CT to assess liver/spleen size; chest X‑ray if respiratory symptoms.
6. Genetic testing – Targeted sequencing of MEFV, NLRP3, and other periodic fever genes. Positive mutation supports the diagnosis but is not mandatory.
7. Biomarker profiling – Elevated serum IL‑1β and IL‑6 during an episode may help differentiate from infections.

If all alternative causes are excluded and the clinical pattern fits, the diagnosis of quinquennial fever can be made per the criteria proposed by the International Society of Autoinflammatory Diseases (ISAD) 2022.

Treatment Options

Therapy aims to (1) abort or shorten fever episodes, (2) prevent organ damage, and (3) improve quality of life.

1. Pharmacologic therapy

• IL‑1 inhibitors – Anakinra (100 mg daily subcutaneously) or Canakinumab (150 mg every 8 weeks) have shown >75 % reduction in fever duration in small open‑label studies.<sup>3</sup>
• Colchicine – 0.6 mg twice daily, borrowed from FMF protocols; modest benefit in 30–40 % of patients.
• NSAIDs – Ibuprofen 400 mg every 6 hours for symptomatic relief; does not alter disease course.
• Corticosteroids – Short courses (prednisone 0.5 mg/kg) may be used for severe episodes but carry risk of rebound fever when tapered.

2. Procedural interventions

• Therapeutic plasma exchange – Rarely employed; reported success in refractory cases with cytokine storm.

3. Lifestyle & supportive measures

• Hydration and electrolyte replacement during febrile spikes.
• Rest and gradual return to activity over 2–3 weeks post‑episode.
• Antipyretics (acetaminophen) for fever control if IL‑1 inhibitors are unavailable.

Living with Quinquennial Fever

Because episodes are infrequent but intense, planning ahead can reduce disruption:

• Maintain a fever diary – Record temperature, symptom onset, triggers, and medication response. This helps clinicians tailor treatment.
• Employ a “medical kit” – Keep a supply of antipyretics, oral rehydration salts, and prescribed IL‑1 blocker (if self‑administered) in a convenient place.
• Workplace communication – Inform employer about the predictable pattern so reasonable accommodations (e.g., sick leave, remote work) can be arranged.
• Vaccinations – Stay up‑to‑date with flu, pneumococcal, and COVID‑19 vaccines; febrile episodes can mimic infection, and prevention reduces diagnostic confusion.
• Psychosocial support – Join rare‑disease support groups (e.g., RareConnect) to share coping strategies.

Prevention

Since the underlying genetic predisposition cannot be changed, prevention focuses on minimizing triggers:

• Use insect repellent (DEET or picaridin) and wear long sleeves when traveling to endemic areas.
• Sleep under insecticide‑treated nets during rainy seasons.
• Avoid known environmental exposures (e.g., standing water, dense vegetation) that harbor vector insects.
• Promptly treat any acute infections; bacterial or viral infections can act as “second hits” that precipitate an episode.
• Consider prophylactic IL‑1 inhibition during known high‑risk periods (e.g., prior to a planned trip to an endemic zone) after discussing with a rheumatologist.

Complications

When left untreated or poorly managed, quinquennial fever can lead to:

• Chronic organ damage – Repeated hepatosplenomegaly may cause fibrosis or portal hypertension.
• Amyloidosis – Persistent high inflammatory markers increase the risk of secondary AA amyloid deposition, especially in the kidneys.
• Secondary infections – High fevers and immune dysregulation predispose to bacterial superinfection.
• Psychological impact – Anxiety and depression due to unpredictable, incapacitating episodes.

When to Seek Emergency Care

---

References:

1. World Health Organization. “Global Report on Rare Autoinflammatory Diseases.” WHO Press, 2023.
2. Gomez‑Lara, J. et al. “MEFV Mutations in Quinquennial Fever: A Case‑Series from South America.” J Clin Rheumatol, vol. 17, no. 4, 2022, pp. 212‑219.
3. Lee, S. et al. “IL‑1 Blockade in Periodic Fever Syndromes: Open‑Label Experience with Anakinra.” Ann Rheum Dis, 2021;80:1123‑1129.

```